We have placed cookies on your device to improve this website. You can change your cookie settings at any time and receive further information regarding cookies . Otherwise, we will assume you're OK to continue.
You are now leaving www.kedrion.at. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
HIGHLIGHTS
CORPORATE
Kedrion Biopharma strengthens its presence in Russia
Memorandum of Understanding with Russian pharmaceutical companies for a joint plasma products manufacturing program
read moreCORPORATE
IVIg efficacy in chronic inflammatory polyradiculoneuropathy (CIDP)
Continuous support by Kedrion Biopharma to research and partnering patient associations
read moreCORPORATE
Kedrion Biopharma consolidates presence on Russian market
Joint venture with Nacimbio of RosTECH group for a technology transfer to Kirov plant
read more-
CORPORATE - 28-12-2016
Kedrion Biopharma strengthens its presence in Russia
Memorandum of Understanding with Russian pharmaceutical companies for a joint plasma products manufacturing program
read more -
CORPORATE - 17-12-2016
IVIg efficacy in chronic inflammatory polyradiculoneuropathy (CIDP)
Continuous support by Kedrion Biopharma to research and partnering patient associations
read more -
CORPORATE - 24-10-2016
Hemophilia seen through children's eyes: Kedrion teams up with LA Kelley
Three books of the series My First Factor Creation are now available for free download
read more -
CORPORATE - 17-06-2016
Kedrion Biopharma consolidates presence on Russian market
Joint venture with Nacimbio of RosTECH group for a technology transfer to Kirov plant
read more
Pages
For more information please contact: pressoffice@kedrion.com
Where 